E-LIB Suche - Ergebnisse für: Hernández, Miguel Teodoro

1

Integrated analysis of randomized controlled trials evaluat..:

Rosiñol, Laura ; Hebraud, Benjamin ; Oriol, Albert...
Frontiers in Oncology. 13 (2023) - p. , 2023

2

Prognostic Value of Serum Paraprotein Response Kinetics in ..:

Tamariz-Amador, Luis-Esteban ; Rodríguez-Otero, Paula ; Jiménez-Ubieto, Ana...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 9 - p. e844-e852 , 2022

Link: https://doi.org/10.1016/..

3

OAB-050: Randomized phase 2 study of weekly carfilzomib 70 ..:

Puertas, Borja ; González, Verónica ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S30-S31 , 2022

Link: https://doi.org/10.1016/..

4

P-224: Single versus tandem autologous stem-cell transplant..:

Villalba, Ana ; Lloret, Pilar ; Rodríguez, Ana Pilar González...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S158 , 2022

Link: https://doi.org/10.1016/..

5

OAB-040: BUMEL vs MEL-200 prior autologous transplant for p..:

Palacios, Juan José Lahuerta ; Ubieto, Ana Jiménez ; Rosiñol, Laura...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S24-S25 , 2022

Link: https://doi.org/10.1016/..

6

Unsupervised machine learning improves risk stratification ..:

Mosquera Orgueira, Adrian ; González Pérez, Marta Sonia ; Diaz Arias, Jose...
Blood Cancer Journal. 12 (2022) 4 - p. , 2022

Link: https://doi.org/10.1038/..

7

OAB-056: A machine learning model based on tumor and immune..:

Guerrero, Camila ; Puig, Noemi ; Cedena, María Teresa...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S35 , 2021

Link: https://doi.org/10.1016/..

8

P-178: Impact of t(11;14) according to induction regimen in..:

Moreno, David ; Oriol, A ; de la Rubia, Javier...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S134-S135 , 2021

Link: https://doi.org/10.1016/..

9

Prognostic utility of serum free light chain ratios and hea..:

Lopez-Anglada, Lucia ; Cueto-Felgueroso, Cecilia ; Rosiñol, Laura...
PLOS ONE. 13 (2018) 9 - p. e0203392 , 2018

Link: https://doi.org/10.1371/..

10

PB2323: R-ESHAP VS R-ICE AS RESCUE TREATMENT IN DIFFUSE LAR..:

Pérez-Pinilla, Belén ; Bonis-Braun, Carolina De ; Saavedra, Minerva Montalvo...
HemaSphere. 7 (2023) S3 - p. e999089d , 2023

Link: https://doi.org/10.1097/..

11

PB2210: COMPARISON OF THREE PROGNOSTIC SCORING SYSTEMS FOR ..:

Raya, Jose Maria ; Gorrín, Kevin Díaz ; Mule, Annalis Serpa...
HemaSphere. 7 (2023) S3 - p. e96531fb , 2023

Link: https://doi.org/10.1097/..

12

P-367 High-risk cytogenetic abnormalities in multiple myelo..:

Rodriguez-Otero, Paula ; Gonzalez-Calle, Veronica ; Calasanz, Maria-Jose...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S241-S242 , 2023

Link: https://doi.org/10.1016/..

13

P-108 Unravelling transplant-ineligible newly diagnosed mul..:

Espinosa, Maria Casanova ; Garcia, Miguel Teodoro Hernandez ; Campos, Juan Alfons Soler...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S93-S94 , 2023

Link: https://doi.org/10.1016/..

14

P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB ..:

Gonzalez-Calle, Veronica ; Rodríguez-Otero, Paula ; Sureda, Anna...
HemaSphere. 7 (2023) S3 - p. e954902c , 2023

Link: https://doi.org/10.1097/..

15

OA-12 Predictors of unsustained measurable residual disease..:

Guerrero, Camila ; Puig, Noemi ; Cedena, Teresa...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S7-S8 , 2023

Link: https://doi.org/10.1016/..